Earnings
41.87 -0.75(-1.75%)05/17/2024
Ultragenyx Pharmaceutical Inc. (RARE)
RARE reported last earnings on 2024-05-02 after the market.
An EPS of $-2.030 was observed compared to an estimated EPS of $-1.72, resulting in a surprise value of $-0.31.
A revenue of $109 million was observed compared to an estimated revenue of $116 million, resulting in a surprise value of $-7 Million.
RARE shares decline -1.08% the day following the earnings announcement to close at 43.22
Ultragenyx Pharmaceutical Inc. (RARE)
Limited historial data were shown. To view all data, Upgrade to PRO plan with only $1
Price Effect : The % change of price from the close before earnings date to the close after the earning date. If earning is Wednesday AfterMarket then this is Wednesday close to Thursday close. If earning is Friday BeforeMarket, then this is Thursday close to Friday close.